The Public Assessment Reports provided are compiled and edited in accordance with EC Directive 2004/27/EC.
In accordance with this Directive, the MHRA makes the assessment reports available for all new licences granted after 30 October 2005, albeit with commercially or personally confidential information removed.
The compilation and editing of the original assessment reports into the Public Assessment Reports are performed by experienced medical writers. The draft copies of the Public Assessment Reports are then checked by medical, pharmaceutical, and, if necessary, preclinical and statistical assessors. The assessment reports are amended to incorporate any assessors’ comments. Before being made available to the public, all Public Assessment Reports are sent to the Marketing Authorisation holder (or a designated person of their choice) for comment.
Latest Public Assessment Reports
-
06 Feb 2012 | Lormetazepam 0.5 and 1 mg Tablets - PL 17507/0131-2
(765Kb)
-
03 Feb 2012 | Amiodarone Hydrochloride 100mg and 200mg Tablets - PL 12762/0190-1
(661Kb)
-
03 Feb 2012 | Puncto Digest capsules, Puncto Travel capsules, Ginger Digest capsules and Ginger Travel capsules (Ginger rhizome) - THR 32294/0012-0015
(3268Kb)
-
03 Feb 2012 | Tradimed Ginger capsules (Ginger rhizome) - THR 32294/0009
(908Kb)
-
03 Feb 2012 | Imipenem/Cilastatin 500mg/500mg Powder for Solution for Infusion - PL 15413/0021;UK/H/2154/001/DC
(2731Kb)
-
02 Feb 2012 | Azafalk 75mg and 100mg Film-Coated Tablets (azathioprine) - PL 08637/0023-4; UK/H/2846/002-3/DC
(2195Kb)
-
01 Feb 2012 | Hedex Extra Tablets (paracetamol, caffeine) - PL 00071/0664
(433Kb)
-
01 Feb 2012 | Gaviscon Fresh Mint Flavour Tablets (sodium alginate, sodium bicarbonate, calcium carbonate) - PL 00063/0678
(1692Kb)
-
01 Feb 2012 | Pantoprazole 40 mg gastro-resistant tablets - UK/H/3355/002/DC; PL 34771/0005
(723Kb)
-
01 Feb 2012 | Ibuprofen 400 mg Capsules, soft - PL 14338/0004-5; UK/H/4611 & 4613/001/DC
(985Kb)


